lactic acid has been researched along with clarithromycin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Collado, MC; Ferrús, MA; González, A; González, R; Hernández, M; Sanz, Y | 1 |
| Adibkia, K; Barzegar-Jalali, M; Ehyaei, N; Lotfipour, F; Mohammadi, G; Nokhodchi, A; Valizadeh, H | 1 |
| Azhdarzadeh, M; Ehyaei, R; Lotfipour, F; Milani, M; Mohammadi, G; Valizadeh, H; Zakeri-Milani, P | 1 |
| Chen, JK; Chu, CH; Huang, HY; Lin, JY; Wang, YC; Wang, YJ; Wu, YT; Yang, CS | 1 |
| Gaikwad, R; Kathariya, R; Pradeep, AR; Raghavendra, NM | 1 |
| Bahrami, N; Ghotaslou, R; Lotfipour, F; Milani, M; Valizadeh, H | 1 |
| Haider, T; Jain, A; Jain, SK; Kumar, A | 1 |
| Akachi, Y; Asaka, T; Kawashima, Y; Moriguchi, K; Ogawa, N; Takahashi, C; Tanemura, M; Yamamoto, H | 1 |
| Alenezi, A; Galli, S; Jimbo, R; Jinno, Y; Naito, Y; Ozeki, T; Prananingrum, W; Tagami, T; Terukina, T | 1 |
1 trial(s) available for lactic acid and clarithromycin
| Article | Year |
|---|---|
Evaluation of subgingivally delivered 0.5% clarithromycin as an adjunct to nonsurgical mechanotherapy in the management of chronic periodontitis: a short-term double blinded randomized control trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Chronic Periodontitis; Clarithromycin; Combined Modality Therapy; Delayed-Action Preparations; Dental Plaque Index; Dental Scaling; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Lactic Acid; Male; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Root Planing | 2014 |
10 other study(ies) available for lactic acid and clarithromycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori.
Topics: Acetic Acid; Adult; Anti-Bacterial Agents; Bifidobacterium; Clarithromycin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Helicobacter pylori; Hot Temperature; Humans; Infant; Lactic Acid; Metronidazole; Microbial Sensitivity Tests; Peptide Hydrolases; Peptides; Species Specificity | 2005 |
Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Carriers; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2011 |
Antibacterial activity of clarithromycin loaded PLGA nanoparticles.
Topics: Anti-Bacterial Agents; Clarithromycin; Escherichia coli; Excipients; Haemophilus influenzae; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Salmonella typhi; Staphylococcus aureus; Streptococcus pneumoniae; Suspensions | 2012 |
Rapid quantitative analysis of clarithromycin in rat plasma by UPLC-MS/MS after intravenous injection of the clarithromycin-loaded ultrafine PLGA nanoparticles.
Topics: Animals; Chromatography, High Pressure Liquid; Clarithromycin; Injections, Intravenous; Lactic Acid; Linear Models; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Solid Phase Microextraction; Tandem Mass Spectrometry | 2012 |
Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Carriers; Helicobacter pylori; Humans; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2016 |
Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Delayed-Action Preparations; Drug Delivery Systems; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydroxamic Acids; Lactic Acid; Lectins; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Stomach | 2016 |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Clarithromycin; Colony Count, Microbial; Drug Carriers; Lactic Acid; Micelles; Microbial Viability; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity | 2017 |
Controlled release of clarithromycin from PLGA microspheres enhances bone regeneration in rabbit calvaria defects.
Topics: Animals; Bone Regeneration; Clarithromycin; Delayed-Action Preparations; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Skull | 2018 |